Photo: Getty ImagesHealth regulators in the United States have halted sales of a type of surgical mesh used to repair pelvic conditions in women, after years of patients' reports of injuries and complications from the implants. The FDA action does not apply to surgical mesh used to treat other conditions such as hernias or incontinence. The agency said on Tuesday that women with the pelvic mesh should continue regular check-ups. Pelvic mesh is the latest medical device for women to have safety issues long after they were approved. Wells Fargo analyst Larry Biegelsen said in an investment note that Boston Scientific's two pelvic mesh products generated about $US25 million ($NZ37 million) in 2018, or less than a fraction of a percent of the company's annual sales.

Source: Otago Daily Times April 16, 2019 23:26 UTC